Myriad CEO Mark Capone notes that the current healthcare system in the U.S. is one of the most effective in the world, but also one of the most inefficient. Molecular diagnostics can help deliver greater efficiency, as well as provide important information for consumers to use in making decisions about their own healthcare.

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.